Todd M. Zimmerman

University of ChicagoChicago, Illinois - 60637 University of Chicago Medical CenterChicago, Illinois - 60637 University of Chicago, School of ...Chicago, Illinois - 60637 (773-834-5358) |
- CLINICAL TRIALS 3
- CONDITIONS2
- INTERVENTIONS7
- SINCE2007

Bendamustine Hydrochloride Lenalidomide and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
February 2010 - December 2014

Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
December 2009 - June 2013

Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
March 2007 - June 2009
Multiple Myeloma
Neoplasms, Plasma Cell
Placebo
Lenalidomide
Bortezomib
Dexamethasone
Panobinostat
Bendamustine Hydrochloride
Npi-0052



